Zobrazeno 1 - 10
of 91
pro vyhledávání: '"van de Vijver, D. A."'
Autor:
Smith, J, Bansi-Matharu, L, Cambiano, V, Dimitrov, D, Bershteyn, A, Van de Vijver, D, Kripke, K, Revill, P, Boily, M-C, Meyer-Rath, G, Taramusi, I, Lundgren, JD, Van Oosterhout, JJ, Kuritzkes, D, Schaefer, R, Siedner, MJ, Schapiro, J, Delany-Moretlwe, S, Landovitz, RJ, Flexner, C, Jordan, M, Venter, F, Radebe, M, Ripin, D, Jenkins, S, Resar, D, Amole, C, Shahmanesh, M, Gupta, RK, Raizes, E, Johnson, C, Inzaule, S, Shafer, R, Warren, M, Stansfield, S, Paredes, R, Phillips, AN, HIV Modelling Consortium
Publikováno v:
The Lancet HIV, 10(4), e254-e265. Elsevier Ltd.
e265
e254
e265
e254
Background: Long-acting injectable cabotegravir pre-exposure prophylaxis (PrEP) is recommended by WHO as an additional option for HIV prevention in sub-Saharan Africa, but there is concern that its introduction could lead to an increase in integrase-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e7dd6628f0fcc01f3d8afaff868fc77
https://pure.eur.nl/en/publications/0ddb9996-8777-47ca-b5bb-83b46ba5d006
https://pure.eur.nl/en/publications/0ddb9996-8777-47ca-b5bb-83b46ba5d006
Autor:
Koopmans, M., de Bruin, E., Godeke, G.-J., Friesema, I., Gageldonk, R. van, Schipper, M., Meijer, A., Binnendijk, R. van, Rimmelzwaan, G.F., Jong, M. D. de, Buisman, A., Beek, J. van, van de Vijver, D., Reimerink, J.
Publikováno v:
In Clinical Microbiology and Infection August 2012 18(8):797-807
Publikováno v:
In Neuromuscular Disorders October 2023 33 Supplement 1:S148-S148
The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health Organization's (WHO) global targ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::e372284c07cc03239a409acf66c525eb
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000058
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3000058
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a 65% red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::eab514bb2a476338e78c377cede35de6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126194
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3126194
Autor:
Wensing, A, Vercauteren, J, Van De Vijver, D, Albert, J, Åsjö, B, Balotta, C, Camacho, R, Coughlan, S, Grossman, Z, Horban, A, Kücherer, C, Nielsen, C, Paraskevis, D, Loke, W, Poggensee, G, Puchhammer Stöckl, E, Riva, C, Ruiz, L, Schmit, J, Schuurman, R, Salminen, M, Sonnerborg, A, Stanojevic, M, Struck, D, Vandamme, A, Boucher, C, TRAMUTO, Fabio, VITALE, Francesco
Publikováno v:
AIDS, 22(5), 625-635. Lippincott Williams & Wilkins
BACKGROUND: The spread of drug-resistant HIV-1 might compromise the future success of current first-line regimens. OBJECTIVE: To analyse the extent and impact of transmission of drug-resistant HIV-1 variants in Europe. DESIGN AND METHODS: The Europea
Publikováno v:
Acta Neurologica Scandinavica. Jan2002, Vol. 105 Issue 1, p8. 5p. 2 Charts, 1 Graph.
Autor:
Frentz, D., Van De Vijver, D., Abecasis, A. B., Albert, Jan, Hamouda, O., Jørgensen, L., Kücherer, C., Struck, D., Schmit, J. -C, Vercauteren, J., Åsjö, Birgitta, Balotta, Claudia, Bergin, C., Beshkov, Danail, Camacho, Ricardo J., Clotet, B., Griskevicius, A., Grossman, Z., Horban, A., Kolupajeva, T., Korn, K., Kostrikis, Leontios G., Linka, K. L. M., Nielsen, C., Otelea, D., Paraskevis, Dimitrios N., Paredes, R., Poljak, M., Puchhammer-Stöckl, E., Sönnerborg, A., Stanekova, D., Stanojevic, M., Vandamme, A. -M, Boucher, C., Wensing, A.
Publikováno v:
PLoS ONE
PLoS ONE, 9(4). Public Library of Science
PLOS ONE
PLoS ONE, Vol 9, Iss 4, p e94495 (2014)
PLoS ONE; Vol 9
e94495
PLoS One (print), 9(4). Public Library of Science
PLoS ONE, 9(4). Public Library of Science
PLOS ONE
PLoS ONE, Vol 9, Iss 4, p e94495 (2014)
PLoS ONE; Vol 9
e94495
PLoS One (print), 9(4). Public Library of Science
BACKGROUND: In Europe, a continuous programme (SPREAD) has been in place for ten years to study transmission of drug resistant HIV. We analysed time trends of transmitted drug resistance mutations (TDRM) in relation to the risk behaviour reported. ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::722b1f7456b51f4c07b828ee864e8ced
http://gnosis.library.ucy.ac.cy/handle/7/53073
http://gnosis.library.ucy.ac.cy/handle/7/53073